I
Ira M. Longini
Researcher at University of Florida
Publications - 290
Citations - 30599
Ira M. Longini is an academic researcher from University of Florida. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 82, co-authored 270 publications receiving 26031 citations. Previous affiliations of Ira M. Longini include University of Minnesota & University of Washington.
Papers
More filters
Journal ArticleDOI
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.
Matteo Chinazzi,Jessica T. Davis,Marco Ajelli,Corrado Gioannini,Maria Litvinova,Stefano Merler,Ana Pastore y Piontti,Kunpeng Mu,Luca Rossi,Kaiyuan Sun,Cécile Viboud,Xinyue Xiong,Hongjie Yu,M. Elizabeth Halloran,M. Elizabeth Halloran,Ira M. Longini,Alessandro Vespignani,Alessandro Vespignani +17 more
TL;DR: The results suggest that early detection, hand washing, self-isolation, and household quarantine will likely be more effective than travel restrictions at mitigating this pandemic, and sustained 90% travel restrictions to and from mainland China only modestly affect the epidemic trajectory unless combined with a 50% or higher reduction of transmission in the community.
Journal ArticleDOI
Containing pandemic influenza at the source.
Ira M. Longini,Azhar Nizam,Shufu Xu,Kumnuan Ungchusak,Wanna Hanshaoworakul,Derek A. T. Cummings,M. Elizabeth Halloran +6 more
TL;DR: Investigation of the effectiveness of targeted antiviral prophylaxis, quarantine, and pre-vaccination in containing an emerging influenza strain at the source showed that a prepared response with targeted antivirals would have a high probability of containing the disease.
Journal ArticleDOI
Mitigation strategies for pandemic influenza in the United States
TL;DR: A large-scale stochastic simulation model is introduced and used to investigate the spread of a pandemic strain of influenza virus through the U.S. population and suggests that the rapid production and distribution of vaccines could significantly slow disease spread and limit the number ill to <10% of the population, particularly if children are preferentially vaccinated.
Journal ArticleDOI
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Ana Maria Henao-Restrepo,Anton Camacho,Ira M. Longini,Conall H. Watson,W. John Edmunds,Matthias Egger,Matthias Egger,Miles W. Carroll,Natalie E. Dean,Ibrahima Dina Diatta,Moussa Doumbia,Bertrand Draguez,Sophie Duraffour,Godwin Enwere,Rebecca F. Grais,Stephan Günther,Pierre Stéphane Gsell,Stefanie Hossmann,Sara Sofie Viksmoen Watle,Mandy Kader Kondé,Sakoba Keita,Souleymane Kone,Eewa Kuisma,Myron M. Levine,Sema Mandal,Thomas Mauget,Gunnstein Norheim,Ximena Riveros,Aboubacar Soumah,Sven Trelle,Andrea S. Vicari,John-Arne Røttingen,Marie Paule Kieny +32 more
TL;DR: The evidence from all 117 clusters showed that no cases of Ebola virus disease occurred 10 days or more after randomisation among all immediately vaccinated contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa.
Journal ArticleDOI
Containing Pandemic Influenza with Antiviral Agents
TL;DR: Targeted antiviral prophylaxis has potential as an effective measure for containing influenza until adequate quantities of vaccine are available and is nearly as effective as vaccinating 80% of the population.